Global Certificate Course in Biotechnology in Antibody Therapeutics
-- viewing nowThe Global Certificate Course in Biotechnology in Antibody Therapeutics is a comprehensive program designed to equip learners with essential skills in the rapidly growing field of antibody therapeutics. This course is crucial in the current industry landscape, where antibody therapeutics are becoming increasingly important in treating various diseases, including cancer and autoimmune disorders.
7,763+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
About this course
100% online
Learn from anywhere
Shareable certificate
Add to your LinkedIn profile
2 months to complete
at 2-3 hours a week
Start anytime
No waiting period
Course details
• Introduction to Biotechnology in Antibody Therapeutics: Overview of biotechnology and its applications in antibody therapeutics, including history, principles, and current trends.
• Antibody Structure and Function: Detailed examination of antibody structure, including heavy and light chains, variable and constant regions, and antibody-antigen interactions. Also covers antibody functions such as neutralization, complement fixation, and antibody-dependent cellular cytotoxicity.
• Monoclonal Antibodies: Production and Applications: Covers the production of monoclonal antibodies, including hybridoma technology, recombinant DNA technology, and phage display. Also covers the applications of monoclonal antibodies in diagnosis, therapy, and research.
• Antibody Engineering and Humanization: Examines the techniques used to engineer antibodies, including affinity maturation, Fc engineering, and humanization. Discusses the advantages and disadvantages of different approaches and their applications in therapy.
• Therapeutic Antibodies: Mechanisms of Action: Discusses the mechanisms of action of therapeutic antibodies, including direct and indirect effects. Covers topics such as receptor binding, signal transduction, and immune effector functions.
• Clinical Development of Antibody Therapeutics: Covers the clinical development of antibody therapeutics, including preclinical studies, clinical trial design, and regulatory considerations. Discusses the challenges and opportunities in developing antibody therapeutics.
• Emerging Trends in Antibody Therapeutics: Explores emerging trends in antibody therapeutics, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors. Discusses the potential of these approaches to transform the field of cancer therapy.
• Challenges and Limitations of Antibody Therapeutics: Examines the challenges and limitations of antibody therapeutics, including issues such as
Career path
Entry requirements
- Basic understanding of the subject matter
- Proficiency in English language
- Computer and internet access
- Basic computer skills
- Dedication to complete the course
No prior formal qualifications required. Course designed for accessibility.
Course status
This course provides practical knowledge and skills for professional development. It is:
- Not accredited by a recognized body
- Not regulated by an authorized institution
- Complementary to formal qualifications
You'll receive a certificate of completion upon successfully finishing the course.
Why people choose us for their career
Loading reviews...
Frequently Asked Questions
Course fee
- 3-4 hours per week
- Early certificate delivery
- Open enrollment - start anytime
- 2-3 hours per week
- Regular certificate delivery
- Open enrollment - start anytime
- Full course access
- Digital certificate
- Course materials
Get course information
Earn a career certificate